Company / SG&A per Share
Fortress Biotech, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$3.14
FY2025
5-year range
$0.64 / $15.43
FY2021-FY2025
Trend
-47.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 10 years, ranging from $-0.40 in FY2016 to $15.43 in FY2023.
Based on SEC 10-K filings.
3.14 in FY2025 with a 5-year CAGR of +33.2%.
Improved from $15.43 to $3.14 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +54.3%
- 5-Year CAGR
- +33.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share decreased 47.9% year-over-year.
- Peak sg&a per share was recorded in FY2023.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.14 | -47.9% |
| FY2024 | $6.03 | -60.9% |
| FY2023 | $15.43 | +1702.2% |
| FY2022 | $0.86 | +32.8% |
| FY2021 | $0.64 | -14.1% |
| FY2020 | $0.75 | -18.6% |
| FY2019 | $0.92 | -7.6% |
| FY2018 | $1.00 | +160.7% |
| FY2017 | $0.38 | +196.4% |
| FY2016 | -$0.40 | -283.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026